Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi An

Showing results (1-10 of 1,304) with videos related to

Pageof 131
Sort By:
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|May 10, 2021
[A Case of De Winter Syndrome with Dynamic ST Segment Evolution]Chao Zhang, Yi An
Experimental and Therapeutic Medicine|December 5, 2017
Blockade of 146b-5p promotes inflammation in atherosclerosis-associated foam cell formation by targeting TRAF6Nan Lin, Yi An
The Urologic Clinics of North America|April 15, 2026
Modern Radiotherapy for High-Risk and Very-High-Risk Prostate AdenocarcinomaJames Shen, Yi An
Pathology, Research and Practice|June 26, 2021
MiR-135a-5p inhibits vascular smooth muscle cells proliferation and migration by inactivating FOXO1 and JAK2 signaling pathwayDong Li, Yi An
Journal of Public Health Dentistry|August 4, 2017
Basic income guarantee: a review of implications for oral healthYi-An Chen, Carlos Quiñonez
The Medical Journal of Australia|September 2, 2023
The not-so-natural herb: a case of exogenous Cushing syndromeYi-An Pan, David Roberts
Seminars in Nephrology|September 10, 2013
Epigenomics: the science of no-longer-junk DNA. Why study it in chronic kidney disease?Yi-An Ko, Katalin Susztak
Journal of Geriatric Cardiology : JGC|July 12, 2012
Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker?Yong-Fang Guo, Yi An
The Australasian Journal of Dermatology|February 16, 2019
Acral angioma serpiginosum: Clinicopathologic and dermoscopic presentationYang Lo, Yi-An Chen
Expert Opinion on Drug Metabolism & Toxicology|August 28, 2009
ABCG2: the key to chemoresistance in cancer stem cells?Yi An, Weg M Ongkeko
Pageof 131

Showing results (1-10 of 1,304) with videos related to

Sort By:
Pageof 131
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|May 10, 2021
[A Case of De Winter Syndrome with Dynamic ST Segment Evolution]Chao Zhang, Yi An
Experimental and Therapeutic Medicine|December 5, 2017
Blockade of 146b-5p promotes inflammation in atherosclerosis-associated foam cell formation by targeting TRAF6Nan Lin, Yi An
The Urologic Clinics of North America|April 15, 2026
Modern Radiotherapy for High-Risk and Very-High-Risk Prostate AdenocarcinomaJames Shen, Yi An
Pathology, Research and Practice|June 26, 2021
MiR-135a-5p inhibits vascular smooth muscle cells proliferation and migration by inactivating FOXO1 and JAK2 signaling pathwayDong Li, Yi An
Journal of Public Health Dentistry|August 4, 2017
Basic income guarantee: a review of implications for oral healthYi-An Chen, Carlos Quiñonez
The Medical Journal of Australia|September 2, 2023
The not-so-natural herb: a case of exogenous Cushing syndromeYi-An Pan, David Roberts
Seminars in Nephrology|September 10, 2013
Epigenomics: the science of no-longer-junk DNA. Why study it in chronic kidney disease?Yi-An Ko, Katalin Susztak
Journal of Geriatric Cardiology : JGC|July 12, 2012
Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker?Yong-Fang Guo, Yi An
The Australasian Journal of Dermatology|February 16, 2019
Acral angioma serpiginosum: Clinicopathologic and dermoscopic presentationYang Lo, Yi-An Chen
Expert Opinion on Drug Metabolism & Toxicology|August 28, 2009
ABCG2: the key to chemoresistance in cancer stem cells?Yi An, Weg M Ongkeko
Pageof 131